Kei Kono
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kei Kono has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Kenichi Ohashi
Department of Pathology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan
5 shared publicationsHiroki Mizuno
Department of Nephrology, Toranomon Hospital, Tokyo, Japan
4 shared publicationsNaoki Sawa
Department of Nephrology, Toranomon Hospital, Tokyo, Japan
4 shared publications- Yoshifumi Ubara
Nephrology Center and the Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan
4 shared publications Yutaka Takazawa
Department of Pathology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan
4 shared publicationsEiko Hasegawa
Department of Nephrology, Toranomon Hospital, Tokyo, Japan
3 shared publications
Latest Publications
- 16 June 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (9) , 1303-1314
Distinct glomerular and tubulointerstitial injury pathways in infective endocarditis-associated glomerulonephritis: a case series
Infective endocarditis-associated glomerulonephritis (IE-GN) causes acute kidney injury with unclear pathogenesis. Previous studies focused on glomerular lesions with limited understanding of tubulointerstitial involvement. We investigated clinicopathological characteristics of renal involvement in IE, focusing on distinct injury patterns in glomeruli and tubulointerstitium. We conducted a retrospective case series of five male patients (age 46-74 years) with confirmed infective endocarditis (IE) who underwent kidney biopsy at Toranomon Hospital between January 1, 2001, and August 31, 2024. The diagnosis of IE was made based on the modified Duke criteria (2011). Blood cultures were positive for Streptococcus (n = 4) and Granulicatella (n = 1). Acute kidney injury was present in three patients with eGFR of 6.5-23.9 mL/min/1.73 m2. Light microscopy revealed two glomerular injury patterns: diffuse endocapillary proliferative glomerulonephritis with neutrophilic infiltration (n = 2) and necrotizing glomerulonephritis with fibrin deposition (n = 3). Patients with severe renal dysfunction demonstrated extensive tubulointerstitial inflammation with neutrophil and macrophage infiltration, while those with preserved renal function showed minimal tubulointerstitial involvement despite similar glomerular immune complex deposition. Immunofluorescence demonstrated granular IgA, IgM, and C3 deposits. Electron microscopy revealed inflammatory cell infiltration, endocapillary proliferation, and subendothelial and mesangial electron-dense deposits. Gram-positive bacteria were detected in one kidney specimen and in cardiac valve vegetation. Patients receiving surgical treatment (n = 3) achieved favorable outcomes. This analysis of five cases suggests that IE-GN involves dual pathogenic pathways: immune complex-mediated glomerular injury and tubulointerstitial injury related to bacterial burden, with tubulointerstitial lesions more strongly associated with renal dysfunction.
- 16 June 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (9) , 1303-1314
Distinct glomerular and tubulointerstitial injury pathways in infective endocarditis-associated glomerulonephritis: a case series
Infective endocarditis-associated glomerulonephritis (IE-GN) causes acute kidney injury with unclear pathogenesis. Previous studies focused on glomerular lesions with limited understanding of tubulointerstitial involvement. We investigated clinicopathological characteristics of renal involvement in IE, focusing on distinct injury patterns in glomeruli and tubulointerstitium. We conducted a retrospective case series of five male patients (age 46-74 years) with confirmed infective endocarditis (IE) who underwent kidney biopsy at Toranomon Hospital between January 1, 2001, and August 31, 2024. The diagnosis of IE was made based on the modified Duke criteria (2011). Blood cultures were positive for Streptococcus (n = 4) and Granulicatella (n = 1). Acute kidney injury was present in three patients with eGFR of 6.5-23.9 mL/min/1.73 m2. Light microscopy revealed two glomerular injury patterns: diffuse endocapillary proliferative glomerulonephritis with neutrophilic infiltration (n = 2) and necrotizing glomerulonephritis with fibrin deposition (n = 3). Patients with severe renal dysfunction demonstrated extensive tubulointerstitial inflammation with neutrophil and macrophage infiltration, while those with preserved renal function showed minimal tubulointerstitial involvement despite similar glomerular immune complex deposition. Immunofluorescence demonstrated granular IgA, IgM, and C3 deposits. Electron microscopy revealed inflammatory cell infiltration, endocapillary proliferation, and subendothelial and mesangial electron-dense deposits. Gram-positive bacteria were detected in one kidney specimen and in cardiac valve vegetation. Patients receiving surgical treatment (n = 3) achieved favorable outcomes. This analysis of five cases suggests that IE-GN involves dual pathogenic pathways: immune complex-mediated glomerular injury and tubulointerstitial injury related to bacterial burden, with tubulointerstitial lesions more strongly associated with renal dysfunction.
- Open Access
- 12 February 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (4)
Ultrasound-guided lateral kidney biopsy in patients unsuitable for the prone position
Background: Kidney biopsy is the gold standard diagnostic technique for nephrologists. Appropriate patient positioning facilitates physiological stability and access to target anatomy. Factors such as patient weight, size and medical history, including respiratory or circulatory disorders, should guide position selection. However, most kidney biopsies are performed exclusively in the prone position and procedures are often deferred when this is not feasible. Although lateral kidney biopsy has been reported, it remains uncommon and its applications are not well established. We aimed to demonstrate the safety and utility of lateral kidney biopsies. Methods: We retrospectively reviewed patients who underwent lateral kidney biopsy at Toranomon Hospital Kajigaya between October 2015 and February 2025. Vital signs and blood test results pre- and post-biopsy were analysed. Results: Twenty-five patients underwent lateral kidney biopsies; six had abdominal aortic aneurysms (AAAs), 12 had respiratory distress (7 with massive ascites or pleural effusions, 2 with obesity, 2 with organomegaly and 1 with pericardial effusion), 6 had major joint pain (4 thin, 1 with scoliosis and 1 with arthritis) and 1 had stoma. All patients were histologically diagnosed and received appropriate treatment. Vital signs remained stable and only one patient with splenomegaly experienced a bleeding complication, which was not readily predictable and unlikely related to biopsy position. Conclusions: Lateral kidney biopsy offers a viable alternative for the accurate diagnosis of kidney diseases in patients in whom the prone position is challenging, including those with AAA, anasarca-induced respiratory distress or significant joint pain due to body habitus.
- 12 February 2026
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 19 (4)
Open AccessUltrasound-guided lateral kidney biopsy in patients unsuitable for the prone position
Background: Kidney biopsy is the gold standard diagnostic technique for nephrologists. Appropriate patient positioning facilitates physiological stability and access to target anatomy. Factors such as patient weight, size and medical history, including respiratory or circulatory disorders, should guide position selection. However, most kidney biopsies are performed exclusively in the prone position and procedures are often deferred when this is not feasible. Although lateral kidney biopsy has been reported, it remains uncommon and its applications are not well established. We aimed to demonstrate the safety and utility of lateral kidney biopsies. Methods: We retrospectively reviewed patients who underwent lateral kidney biopsy at Toranomon Hospital Kajigaya between October 2015 and February 2025. Vital signs and blood test results pre- and post-biopsy were analysed. Results: Twenty-five patients underwent lateral kidney biopsies; six had abdominal aortic aneurysms (AAAs), 12 had respiratory distress (7 with massive ascites or pleural effusions, 2 with obesity, 2 with organomegaly and 1 with pericardial effusion), 6 had major joint pain (4 thin, 1 with scoliosis and 1 with arthritis) and 1 had stoma. All patients were histologically diagnosed and received appropriate treatment. Vital signs remained stable and only one patient with splenomegaly experienced a bleeding complication, which was not readily predictable and unlikely related to biopsy position. Conclusions: Lateral kidney biopsy offers a viable alternative for the accurate diagnosis of kidney diseases in patients in whom the prone position is challenging, including those with AAA, anasarca-induced respiratory distress or significant joint pain due to body habitus.
- Open Access
- 9 January 2026
- Published by Elsevier in Kidney Medicine
- Vol. 8 (3)
When Hepatitis B Virus-Associated Glomerulonephritis Mimics Lupus Nephritis: A Case of Adult-Onset Disease With Full-House Pattern
- 9 January 2026
- Published by Elsevier in Kidney Medicine
- Vol. 8 (3)
Open AccessWhen Hepatitis B Virus-Associated Glomerulonephritis Mimics Lupus Nephritis: A Case of Adult-Onset Disease With Full-House Pattern
- 28 October 2025
- Published by Wiley in Pathology International
- Vol. 76 (1)
Progressive Estrogen Receptor Acquisition During Malignant Transformation: Insights From MCN‐Derived Anaplastic Pancreatic Carcinoma
Anaplastic pancreatic carcinoma (APC) arising from mucinous cystic neoplasm (MCN) is rare, with only 12 cases reported. The relationship between pregnancy‐associaed hormonal changes and MCN progression remains poorly understood, particularly regarding hormone receptor expression patterns during malignant transformation. A 34‐year‐old woman presented with persistent abdominal pain 9 months post‐delivery. Imaging revealed an 11 cm multilocular cystic mass in the pancreatic body and tail with mural nodules showing blood flow signals. Laboratory findings demonstrated normal. She underwent distal pancreatectomy and splenectomy and no recurrence at 6‐month follow‐up. Histopathological examination revealed MCN with ovarian‐type stroma progressing from low‐to‐high grade dysplasia, invasive ductal carcinoma, and anaplastic carcinoma with osteoclast‐like giant cells. Immunohistochemically, estrogen receptor (ER) expression showed stepwise pattern: negative in low‐grade dysplasia, strongly positive in high‐grade dysplasia and anaplastic components. Progesterone receptor positivity was observed in stromal and epithelial components, with elevated Ki‐67 correlating with ER expression. This represents first documentation of progressive ER acquisition during MCN malignant transformation, suggesting autonomous hormone production by ovarian‑type stroma may help sustain tumor growth beyond pregnancy. Stepwise ER expression may serve as a biomarker for risk stratification and a potential target for therapy in hormone‐sensitive pancreatic neoplasms.
- 28 October 2025
- Published by Wiley in Pathology International
- Vol. 76 (1)
Progressive Estrogen Receptor Acquisition During Malignant Transformation: Insights From MCN‐Derived Anaplastic Pancreatic Carcinoma
Anaplastic pancreatic carcinoma (APC) arising from mucinous cystic neoplasm (MCN) is rare, with only 12 cases reported. The relationship between pregnancy‐associaed hormonal changes and MCN progression remains poorly understood, particularly regarding hormone receptor expression patterns during malignant transformation. A 34‐year‐old woman presented with persistent abdominal pain 9 months post‐delivery. Imaging revealed an 11 cm multilocular cystic mass in the pancreatic body and tail with mural nodules showing blood flow signals. Laboratory findings demonstrated normal. She underwent distal pancreatectomy and splenectomy and no recurrence at 6‐month follow‐up. Histopathological examination revealed MCN with ovarian‐type stroma progressing from low‐to‐high grade dysplasia, invasive ductal carcinoma, and anaplastic carcinoma with osteoclast‐like giant cells. Immunohistochemically, estrogen receptor (ER) expression showed stepwise pattern: negative in low‐grade dysplasia, strongly positive in high‐grade dysplasia and anaplastic components. Progesterone receptor positivity was observed in stromal and epithelial components, with elevated Ki‐67 correlating with ER expression. This represents first documentation of progressive ER acquisition during MCN malignant transformation, suggesting autonomous hormone production by ovarian‑type stroma may help sustain tumor growth beyond pregnancy. Stepwise ER expression may serve as a biomarker for risk stratification and a potential target for therapy in hormone‐sensitive pancreatic neoplasms.
- Open Access
- 8 August 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (3) , 373-384
Effectiveness of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors on Esophageal Wall Thickening in Eosinophilic Esophagitis
The efficacy of proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) in the treatment of eosinophilic esophagitis (EoE) has been well established. This study aimed to clarify the impact of PPIs/P-CABs on esophageal wall thickness and clinical symptoms in EoE patients. Patients who were consecutively diagnosed with asymptomatic esophageal eosinophilia and EoE and treated with PPIs/P-CABs were assessed in this study. Esophageal wall thickness before and after treatment was evaluated using endoscopic ultrasonography. Thirteen patients were asymptomatic, while 20 presented with gastrointestinal symptoms at baseline. Treatment led to significant decreases in symptom scores, the EoE Endoscopic Reference Scores, and the EoE Histologic System Scores compared with those at baseline. Following treatment, significant reductions were observed in the total esophageal wall thickness (TWT) and thickness from the surface to the muscular layer (TSM) across the upper, middle, and lower esophagus compared with baseline values (median TWT, 2.0 mm vs 1.7 mm, p=0.005; 2.3 mm vs 1.9 mm, p=0.004; 2.9 mm vs 2.3 mm, p<0.001; median TSM, 1.1 mm vs 0.9 mm, p=0.001; 1.3 mm vs 1.1 mm, p<0.001; 1.8 mm vs 1.4 mm, p<0.001, respectively). Similar trends were observed in the lower esophagus of patients with asymptomatic esophageal eosinophilia, with the TWT and TSM values significantly lower after treatment (median TWT, 2.7 mm vs 2.5 mm, p=0.045; median TSM, 1.7 mm vs 1.5 mm, p=0.008, respectively). These findings were consistent in patients treated with either PPIs (p=0.027 and p=0.018, respectively) or P-CABs (p<0.001 and p<0.001, respectively). PPIs/P-CABs reduce esophageal wall thickening, particularly in the mucosal and submucosal layers.
- 8 August 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (3) , 373-384
Open AccessEffectiveness of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors on Esophageal Wall Thickening in Eosinophilic Esophagitis
The efficacy of proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) in the treatment of eosinophilic esophagitis (EoE) has been well established. This study aimed to clarify the impact of PPIs/P-CABs on esophageal wall thickness and clinical symptoms in EoE patients. Patients who were consecutively diagnosed with asymptomatic esophageal eosinophilia and EoE and treated with PPIs/P-CABs were assessed in this study. Esophageal wall thickness before and after treatment was evaluated using endoscopic ultrasonography. Thirteen patients were asymptomatic, while 20 presented with gastrointestinal symptoms at baseline. Treatment led to significant decreases in symptom scores, the EoE Endoscopic Reference Scores, and the EoE Histologic System Scores compared with those at baseline. Following treatment, significant reductions were observed in the total esophageal wall thickness (TWT) and thickness from the surface to the muscular layer (TSM) across the upper, middle, and lower esophagus compared with baseline values (median TWT, 2.0 mm vs 1.7 mm, p=0.005; 2.3 mm vs 1.9 mm, p=0.004; 2.9 mm vs 2.3 mm, p<0.001; median TSM, 1.1 mm vs 0.9 mm, p=0.001; 1.3 mm vs 1.1 mm, p<0.001; 1.8 mm vs 1.4 mm, p<0.001, respectively). Similar trends were observed in the lower esophagus of patients with asymptomatic esophageal eosinophilia, with the TWT and TSM values significantly lower after treatment (median TWT, 2.7 mm vs 2.5 mm, p=0.045; median TSM, 1.7 mm vs 1.5 mm, p=0.008, respectively). These findings were consistent in patients treated with either PPIs (p=0.027 and p=0.018, respectively) or P-CABs (p<0.001 and p<0.001, respectively). PPIs/P-CABs reduce esophageal wall thickening, particularly in the mucosal and submucosal layers.
- 28 February 2025
- Published by Springer Nature in CEN Case Reports
- Vol. 14 (3) , 434-441
A case of IgG-type heavy chain amyloidosis with membranous nephropathy-like changes with long-term survival
We performed a kidney biopsy on a 68-year-old man with 2.6 g/day proteinuria. Immunofluorescence (IF) study showed a positive finding of IgG (IgG1) along the glomerular capillary wall, suggesting membranous nephropathy. However, electron microscopy showed no subepithelial electron dense deposits and amorphous deposits of 8–12 nm fibrillar structure, and positive DFS/Congo red staining confirmed the diagnosis of amyloidosis. Amyloid deposits were localized only in the glomeruli. No overt extrarenal amyloid lesions were identified. Serum and urine were positive for monoclonal IgG-lambda, but IF was negative for kappa and lambda, ruling out AL-amyloidosis. At 75 years of age, he underwent a second kidney biopsy, and the IgG-positive findings at IF became more pronounced, with progressive glomerular sclerosing lesions. A proteomic analysis was performed focusing on the positive IgG finding in IF. The amyloid was proven to be composed of fragments of a heavy chain variable region sequence. AH-amyloidosis was the final diagnosis. He was treated according to the treatment for AL-amyloidosis, but hemodialysis was started at the age of 81, and died at the age of 86. We report a valuable case of AH-amyloidosis with an observed long-term prognosis.
- 28 February 2025
- Published by Springer Nature in CEN Case Reports
- Vol. 14 (3) , 434-441
A case of IgG-type heavy chain amyloidosis with membranous nephropathy-like changes with long-term survival
We performed a kidney biopsy on a 68-year-old man with 2.6 g/day proteinuria. Immunofluorescence (IF) study showed a positive finding of IgG (IgG1) along the glomerular capillary wall, suggesting membranous nephropathy. However, electron microscopy showed no subepithelial electron dense deposits and amorphous deposits of 8–12 nm fibrillar structure, and positive DFS/Congo red staining confirmed the diagnosis of amyloidosis. Amyloid deposits were localized only in the glomeruli. No overt extrarenal amyloid lesions were identified. Serum and urine were positive for monoclonal IgG-lambda, but IF was negative for kappa and lambda, ruling out AL-amyloidosis. At 75 years of age, he underwent a second kidney biopsy, and the IgG-positive findings at IF became more pronounced, with progressive glomerular sclerosing lesions. A proteomic analysis was performed focusing on the positive IgG finding in IF. The amyloid was proven to be composed of fragments of a heavy chain variable region sequence. AH-amyloidosis was the final diagnosis. He was treated according to the treatment for AL-amyloidosis, but hemodialysis was started at the age of 81, and died at the age of 86. We report a valuable case of AH-amyloidosis with an observed long-term prognosis.
- 7 October 2024
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 99 (11) , 1687-1688
A Case of IgD-λ Light Chain Cast Nephropathy Associated With Crystalline Formation and Monoclonal Gammopathy of Undetermined Significance
- 7 October 2024
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 99 (11) , 1687-1688
A Case of IgD-λ Light Chain Cast Nephropathy Associated With Crystalline Formation and Monoclonal Gammopathy of Undetermined Significance
- 17 July 2024
- Published by Wiley in Pathology International
- Vol. 74 (9) , 508-519
Digital whole‐slide imaging of changes in amyloid after peripheral blood stem cell transplantation in patients with amyloid light‐chain amyloidosis
Peripheral blood stem cell transplantation (PBSCT) has made amyloid light‐chain (AL) amyloidosis treatable. After PBSCT, hematological complete remission (HCR) can be achieved, leading to improved renal prognosis. The purpose of this study was to evaluate whether whole slide imaging of biopsy samples shows a post‐treatment reduction in amyloid deposits in patients with AL amyloidosis. Patients were divided into three groups: Group A (n = 8), not eligible for PBSCT and treated with other therapies; Group B (n = 11), treated with PBSCT and achieved HCR; and Group C (n = 5), treated with PBSCT but did not achieve HCR. Clinical findings and amyloid deposition in glomeruli, interstitium, and blood vessels were compared before and after treatment using digital whole‐slide imaging. Proteinuria and hypoalbuminemia improved more in Group B than in the other groups, and in Group B, amyloid deposition improved more in the glomeruli than in the interstitium and blood vessels. The long‐term renal and survival prognosis was better in Group B than in the other groups. PBSCT can be expected to improve long‐term clinical and renal histological prognosis in patients with AL amyloidosis who achieve HCR. Amyloid disappearance from renal tissue may take a long time even after clinical HCR.
- 17 July 2024
- Published by Wiley in Pathology International
- Vol. 74 (9) , 508-519
Digital whole‐slide imaging of changes in amyloid after peripheral blood stem cell transplantation in patients with amyloid light‐chain amyloidosis
Peripheral blood stem cell transplantation (PBSCT) has made amyloid light‐chain (AL) amyloidosis treatable. After PBSCT, hematological complete remission (HCR) can be achieved, leading to improved renal prognosis. The purpose of this study was to evaluate whether whole slide imaging of biopsy samples shows a post‐treatment reduction in amyloid deposits in patients with AL amyloidosis. Patients were divided into three groups: Group A (n = 8), not eligible for PBSCT and treated with other therapies; Group B (n = 11), treated with PBSCT and achieved HCR; and Group C (n = 5), treated with PBSCT but did not achieve HCR. Clinical findings and amyloid deposition in glomeruli, interstitium, and blood vessels were compared before and after treatment using digital whole‐slide imaging. Proteinuria and hypoalbuminemia improved more in Group B than in the other groups, and in Group B, amyloid deposition improved more in the glomeruli than in the interstitium and blood vessels. The long‐term renal and survival prognosis was better in Group B than in the other groups. PBSCT can be expected to improve long‐term clinical and renal histological prognosis in patients with AL amyloidosis who achieve HCR. Amyloid disappearance from renal tissue may take a long time even after clinical HCR.